By Charles Toutant | February 21, 2020
Antitrust claims are a product of federal statute and thus are extrinsic to, and not rights "under," a commercial agreement, the appeals court said.
By Amanda Bronstad | February 10, 2020
The defendants supported the District of New Jersey, where Sanofi has its U.S. headquarters, or the Southern District of New York, home to Pfizer. The U.S. Judicial Panel on Multidistrict Litigation chose the Southern District of Florida.
By Mike Scarcella | February 7, 2020
Novo Nordisk, represented by lawyers from Morgan, Lewis & Bockius, is locked in a dispute with BioMarin Pharmaceutical, represented by Jones Day, in courts in Massachusetts, Texas, New York and California. A Boston judge on Wednesday declined to issue a temporary restraining order.
By Max Mitchell | January 27, 2020
The newly filed cases were swiftly removed to federal court, but judges are now wading into novel issues that determine whether they should ultimately be remanded or transferred.
By Charles Toutant | January 17, 2020
The appeals court upheld a 2017 ruling barring testimony from experts who linked Accutane to certain side effects.
By Max Mitchell | January 17, 2020
The two-sentence order did not outline the reasoning for drastically cutting the $8 billion jury award but it brings the punitive damages award to 10 times the $680,000 compensatory award.
By Zach Warren | January 10, 2020
As part of the Legalweek 2020 Q&A series, Legaltech News speaks with GSK e-discovery lead Francine French for the how and why her legal department has developed chatbots.
By Phillip Bantz | December 10, 2019
Gottlieb Keller will retire in March after serving as GC for more than a decade. His successor, Claudia Böckstiegel, is being promoted from her post as legal head of Roche's diagnostics division.
The Legal Intelligencer | News
By Zack Needles | November 26, 2019
The Pennsylvania Superior Court has ruled that a $70 million jury verdict against Johnson & Johnson subsidiary Janssen and in favor of a child allegedly injured by antipsychotic drug Risperdal was not excessive, and has also remanded the case for a second look at whether there should be a punitive damages trial.
By Charles Toutant | November 25, 2019
Merck's opportunity for a new hearing is a victory for lawyers from King & Spalding, Skadden Arps Slate Meagher & Flom, Fox Rothschild, McCarter & English, Jones Day and Venable.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...